Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study.

Giovanni Lo Re,Davide A Santeufemia,Francesco Lo Re,Roberto Bortolus,Paolo Doretto,Wally Marus, Lorenzo Buttazzi, Oliviero Lenardon, Alessandra Falda, Rita Piazza,Sandro Sulfaro

Cytokine（2020）

引用 12|浏览17

暂无评分

摘要

•Feasibility, safety, activity and tolerability of IL-2 chronoinfusion in metastatic RCC.•Prognostic value of prolactin and MSKCC score on survival.•Prognostic value of IL-2 dose and ECOG performance score on survival.•Long-term survival with IL-2 chronoinfusion in metastatic RCC.

查看译文

关键词

Interleukin-2,Metastatic renal cancer,Chrono-infusion,Tyrosine kinase inhibitors,Programmated death 1 antibody

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要